Search people, articles, bills, and more
Voters should care about this bill because it aims to accelerate the discovery of new treatments and cures for some of the most challenging and widespread health issues in the United States: neurodegenerative diseases and psychiatric conditions. Millions of Americans suffer from conditions like Alzheimer's, Parkinson's, depression, and anxiety, which impose significant burdens on individuals, families, and the healthcare system.
If this bill becomes law, it could incentivize private companies to invest more heavily in the critical, often expensive, 'translational research' phase — the bridge between basic lab science and practical patient applications. This could lead to faster development of innovative drugs, therapies, and devices. If it doesn't pass, research and development in these areas would likely continue at current paces, potentially delaying breakthroughs that could alleviate suffering and reduce healthcare costs for many.
No reactions yet. Be the first to weigh in.
Voters should care about this bill because it aims to accelerate the discovery of new treatments and cures for some of the most challenging and widespread health issues in the United States: neurodegenerative diseases and psychiatric conditions. Millions of Americans suffer from conditions like Alzheimer's, Parkinson's, depression, and anxiety, which impose significant burdens on individuals, families, and the healthcare system.
If this bill becomes law, it could incentivize private companies to invest more heavily in the critical, often expensive, 'translational research' phase — the bridge between basic lab science and practical patient applications. This could lead to faster development of innovative drugs, therapies, and devices. If it doesn't pass, research and development in these areas would likely continue at current paces, potentially delaying breakthroughs that could alleviate suffering and reduce healthcare costs for many.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| AMOUNT | PROGRAM | TYPE | YEARS |
|---|---|---|---|
| $1,000,000,000 | Translational Research Credit Limitation | discretionary | 2026 |
| $2,000,000,000 | Translational Research Credit Limitation | discretionary | 2027-2030 |
| $1,000,000,000 | Translational Research Credit Limitation | discretionary | 2031 |